The macrocyclic triene 34, an advanced intermediate for synthesis of phomactins, has been synthesized using the 2,3-Wittig rearrangement of the propargylic ether 21 as a key step.
Corrigendum to “Approaches to the total synthesis of phomactins”: [Tetrahedron Lett. 44 (2003) 2713]
✍ Scribed by Andrew S Balnaves; Graham McGowan; Peter D.P Shapland; Eric J Thomas
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- French
- Weight
- 56 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
✦ Synopsis
Footnote 5 of the above Tetrahedron Letter states that ''The spontaneous rearrangement of Sch. 49028 into phomactin A was observed by Pattenden et al. during their synthesis, see ref. 4. 1 '' However, it should be made absolutely clear that Goldring and Pattenden did not state in their paper 1 that Sch. 49028 spontaneously rearranged into phomactin A. These authors did not isolate Sch. 49028 (still attributed the originally assigned 2 hydroxy-epoxide structure 1 in the above Tetrahedron Letter) and could not therefore study its rearrangement.
In the final step of their synthesis of phomactin A 2, 1 Goldring and Pattenden deprotected the bis-p-methoxybenzyl ether 3 and isolated phomactin A 2 directly. They did not isolate the hydroxyepoxide 1 (Sch. 49028?) although it may be an intermediate in the conversion of 3 into 2. Moreover, there is some doubt as to whether the compound identified as Sch. 49028 was correctly identified originally 2 as the hydroxyepoxide 1 or whether it should have been identified as phomactin A 2 since the NMR spectrum reported for Sch. 49028 2 in deuterated chloroform was found by both Pattenden 1 and Halcomb 3 to correspond to that of synthetic phomactin A 2.
📜 SIMILAR VOLUMES
The Publisher regrets that the oxygen atom and the double bond of the carbonyl group of structure 5 of Scheme 1 were omitted. The correct version is printed below: Scheme 1.
Scheme 2. Retrosynthetic analysis of reported structure 3 and biosynthetically expected isomer 4.
The authors regret that the structures of 14-17 in Scheme 3 have been drawn incorrectly. The corrected Scheme is shown below. Scheme 3. (a) LAH, THF, 0°C-rt, 4 h; (b) TBDPS-Cl, imidazole, DCM, 0°C-rt, 2 h; (c) DEAD, TPP, p-NO 2 C 6 H 4 -COOH, THF, 0°C-rt; (d) Dess-Martin periodinane, DCM, rt, 2 h; (